Nick Miles, leader of the Asia private capital advisory team at Lazard, has taken on a newly created role intended to enhance collaboration between the firm’s operations in Asia and Europe.
Miles, who has been with Lazard for 13 years, will continue to be based in Singapore but spend more time in London as head of Asia Pacific and European private equity. The new position is intended to formalize...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.